APYX Medical Corp Files 8-K on Security Holder Vote
Ticker: APYX · Form: 8-K · Filed: Aug 13, 2025 · CIK: 719135
| Field | Detail |
|---|---|
| Company | Apyx Medical Corp (APYX) |
| Form Type | 8-K |
| Filed Date | Aug 13, 2025 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-meeting
TL;DR
APYX Medical Corp is having a shareholder vote soon, details to follow.
AI Summary
On August 7, 2025, APYX Medical Corporation filed an 8-K report detailing a submission of matters to a vote of security holders. The filing does not contain specific details about the nature of the vote or any financial transactions.
Why It Matters
This filing indicates a procedural step where shareholders will be asked to vote on certain company matters, which could potentially impact corporate governance or strategic decisions.
Risk Assessment
Risk Level: low — The filing is a standard procedural notification and does not disclose any immediate financial risks or significant operational changes.
Key Players & Entities
- APYX Medical Corporation (company) — Registrant
- August 7, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Clearwater, Florida (location) — Principal executive offices
FAQ
What specific matters will be submitted for a vote of security holders?
The filing does not specify the exact matters to be voted on, only that a submission of matters to a vote of security holders is occurring.
When is the shareholder vote expected to take place?
The filing reports the date of the earliest event as August 7, 2025, but does not provide a date for the actual vote.
Has APYX Medical Corporation provided any details regarding the agenda for the shareholder vote?
No, this 8-K filing does not include details about the agenda for the shareholder vote.
What is the significance of filing an 8-K for a submission of matters to a vote?
An 8-K filing is required to promptly inform investors of material events, such as when a company plans to submit significant matters for shareholder approval.
Are there any financial implications mentioned in this filing related to the shareholder vote?
This filing does not mention any specific financial implications or transactions related to the matters to be voted on.
Filing Stats: 804 words · 3 min read · ~3 pages · Grade level 15.9 · Accepted 2025-08-13 16:00:32
Filing Documents
- form8-k.htm (8-K) — 55KB
- form8-k_001.jpg (GRAPHIC) — 7KB
- 0001641172-25-023451.txt ( ) — 235KB
- apyx-20250807.xsd (EX-101.SCH) — 3KB
- apyx-20250807_lab.xml (EX-101.LAB) — 33KB
- apyx-20250807_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: August 13, 2025 Apyx Medical Corporation By: /s/ Matthew Hill Matthew Hill Chief Financial Officer, Secretary and Treasurer